Management of metastatic prostate cancer.
Metastatic prostate cancer remains an incurable disease. However, palliative treatment based on hormonal manipulation can effectively control symptoms and prolong life. The development of progressive "hormone-refractory disease" requires a multidisciplinary approach, with the involvement of general practitioners, urologists, radiation oncologists, medical oncologists and palliative care physicians. Some of the newer therapies, such as chemotherapy, have proved successful in improving the quality of life for many patients, and modern palliative care techniques can provide good symptom control.
Department of Clinical Haematology and Medical Oncology, Royal Melbourne Hospital, Vic. Rosenthal@licre.ludwig.edu.au
M A
MA
Rosenthal
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols; D001315:Australia / Q000453:epidemiology; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D010166:Palliative Care; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000556:secondary* / Q000628:therapy*
D018931:Antineoplastic Agents, Hormonal